लोड हो रहा है...

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab

Introduction We present a case of a patient with osteoporosis and chronic kidney disease (CKD)-induced secondary hyperparathyroidism who developed severe hypophosphatemia and increasing parathyroid hormone (PTH) level after receiving Denosumab. Clinical Case 90-year-old male with CKD stage 3 present...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Endocr Soc
मुख्य लेखकों: Adepoju, Yewande, Khitan, Zeid, Khthir, Rodhan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Endocrine Society 2019
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553052/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-514
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!